查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1225536

体内 CRO 市场：2023-2028 年全球行业趋势、份额、规模、增长、机遇和预测

In-vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

市场概览

  • 到 2022 年，全球体内 CRO 市场规模将达到 46 亿美元。 展望未来，IMARC Group 预测到 2028 年将达到 74 亿美元，显示 2023 年至 2028 年之间的增长率 (CAGR) 为 8.07%。
  • 体内合同研究组织 (CRO) 是根据合同开展广泛生物製药研究的机构。 我们通过提供外包服务支持製药和生物技术公司开发有效的药物、疫苗和医疗设备。 与体外 CRO 相比，体内 CRO 处理在体内进行的研究，进行人体临床试验以评估药物安全性和有效性，而不是对分离的细胞或组织进行测试。 我们帮助研究机构管理复杂的医学测试，以最低的成本开发有效的药物，并通过避免延迟招募、资金和临床准备来优化工作流程。 因此，体内 CRO 具有广泛的应用，包括疼痛管理、肿瘤学以及中枢神经系统 (CNS) 损伤和其他疾病的治疗。 现在分为囓齿类和非囓齿类。

体内CRO市场趋势

  • 各种心血管疾病(尤其是老年人)的患病率不断上升，以及对有效药物和新的基于肿瘤的诊断和治疗疗法的需求不断增长，是市场增长的主要驱动力。 在其他活动中，合同研究开发和製造组织 (CRDMO) 对活性药物成分 (API) 临床规模製造的需求不断增加，以及从单克隆抗体向生物仿製药的转变正在成为增长动力。 此外，日益严重的健康问题促使生物技术公司与 CRO 合作开发有效的新型疫苗，尤其是在 COVID-19 流行期间，这有助于市场增长。 此外，在临床前试验期间广泛使用体内 CRO 进行毒理学和药代动力学研究也推动了市场增长。 除此之外，生物等效性的出现、仿製药的激增、专利到期的增加以及个性化药物设计的持续研发 (R&D) 活动为市场带来了光明的前景。

主要市场细分

  • IMARC Group 分析了全球体内 CRO 市场报告每个子部分的主要趋势，并预测了 2023 年至 2028 年在全球、区域和国家层面的情况。 该报告根据类型、GLP 类型和适应症对市场进行分类。

按类型细分

  • 囓齿动物
  • 大鼠
  • 鼠标
  • 其他
  • 非囓齿动物

按 GLP 类型细分

  • 非 GLP
  • 内部
  • 外包
  • GLP 毒理学
  • 内部
  • 外包

按适应症分类

  • 自身免疫性疾病和炎症性疾病
  • 类风湿性关节炎
  • 多发性硬化症
  • 骨关节炎
  • 肠易激综合征
  • 其他
  • 疼痛管理
  • 慢性疼痛
  • 剧痛
  • 肿瘤学
  • 血癌
  • 实体癌
  • 其他
  • 中枢神经系统疾病
  • 癫痫症
  • 帕金森病
  • 亨廷顿舞蹈症
  • 中风
  • 创伤性脑损伤
  • 肌萎缩侧索硬化
  • 肌肉再生
  • 其他
  • 糖尿病
  • 肥胖
  • 其他

按地区划分

  • 北美
  • 美国
  • 加拿大
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚
  • 印度尼西亚
  • 其他
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中东和非洲

本报告中回答的关键问题

  • 全球体内 CRO 市场迄今为止发生了怎样的变化，未来又将发生怎样的变化？
  • COVID-19 对全球体内 CRO 市场有何影响？
  • 您的主要区域市场是什么？
  • 按类型划分的市场细分是什么？
  • 基于 GLP 类型的市场细分是什么？
  • 基于指示的市场细分是什么？
  • 行业价值链中有哪些不同阶段？
  • 该行业的主要驱动因素和挑战是什么？
  • 全球体内 CRO 市场的结构如何？主要参与者有哪些？
  • 您所在行业的竞争力如何？

内容

第1章前言

第 2 章研究方法和范围

  • 调查的目的
  • 利益相关者
  • 数据来源
    • 主要信息
    • 次要信息
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章执行摘要

第4章介绍

  • 概览
  • 主要行业趋势

第 5 章全球体内 CRO 市场

  • 市场概览
  • 市场结果
  • COVID-19 的影响
  • 市场预测

第 6 章按类型划分的市场细分

  • 囓齿动物
    • 市场趋势
    • 主要细分市场
      • 大鼠
      • 鼠标
      • 其他
    • 市场预测
  • 非囓齿动物
    • 市场趋势
    • 市场预测

第 7 章按 GLP 类型划分的市场细分

  • 非 GLP
    • 市场趋势
    • 主要细分市场
      • 内部
      • 外包
    • 市场预测
  • GLP 毒理学
    • 市场趋势
    • 主要细分市场
      • 内部
      • 外包
    • 市场预测

第 8 章按适应症划分的市场细分

  • 自身免疫性疾病和炎症性疾病
    • 市场趋势
    • 主要细分市场
      • 类风湿性关节炎
      • 多发性硬化症
      • 骨关节炎
      • 肠易激综合征
      • 其他
    • 市场预测
  • 疼痛管理
    • 市场趋势
    • 主要细分市场
      • 慢性疼痛
      • 剧痛
    • 市场预测
  • 肿瘤科
    • 市场趋势
    • 主要细分市场
      • 血癌
      • 实体癌
      • 其他
    • 市场预测
  • 中枢神经系统疾病
    • 市场趋势
    • 主要细分市场
      • 癫痫症
      • 帕金森病
      • 亨廷顿舞蹈症
      • 中风
      • 创伤性脑损伤
      • 肌萎缩侧索硬化
      • 肌肉再生
      • 其他
    • 市场预测
  • 糖尿病
    • 市场趋势
    • 市场预测
  • 肥胖
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 9 章按区域划分的市场细分

  • 北美
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场展望
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场展望
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场展望
    • 韩国市场
      • 市场趋势
      • 市场展望
    • 澳大利亚
      • 市场趋势
      • 市场展望
    • 印度尼西亚
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场展望
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场展望
    • 西班牙
      • 市场趋势
      • 市场展望
    • 俄罗斯
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场展望
    • 墨西哥
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家/地区划分的市场细分
    • 市场展望

第 10 章 SWOT 分析

  • 概览
  • 强度
  • 弱点
  • 机会
  • 威胁

第11章价值链分析

第12章搬运工五力分析

  • 概览
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章竞争格局

  • 市场结构
  • 主要公司
  • 主要公司简介
    • Charles River Laboratories International Inc.
    • Evotec SE
    • ICON plc
    • Iris Pharma(ABIONYX Pharma)
    • Labcorp Drug Development(Laboratory Corporation of America Holdings)
    • North American Science Associates LLC
    • Parexel International Corporation
    • Pharmaceutical Product Development Inc.(Thermo Fisher Scientific Inc.)
    • Pronexus Analytical AB
    • Syneos Health
    • WuXi AppTec
Product Code: SR1423A377_Report

Market Overview:

  • The global in-vivo CRO market size reached US$ 4.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 7.4 Billion by 2028, exhibiting a growth rate (CAGR) of 8.07% during 2023-2028.
  • In-vivo contract research organizations (CROs) are institutions that conduct extensive biopharmaceutical research on a contractual basis. They support pharmaceutical and biotechnology companies in formulating effective drugs, vaccines, and medical devices by providing outsourcing services. As compared to in-vitro CRO, in-vivo CRO deals with the research performed within the living organism and conducts human clinical trials to assess the safety and efficacy of the drugs instead of organizing examinations on removed cells and tissues. They aid research institutions in managing complex medical testing, developing effective medications at minimal costs, and optimizing workflow by avoiding delays caused by hiring, fundraising, and clinical preparations. As a result, in-vivo CRO finds extensive application in pain management, oncology, and treating central nervous system (CNS) injuries and other disorders. Currently, they are bifurcated into rodent- and non-rodent-based types.

In-vivo CRO Market Trends:

  • The increasing prevalence of various cardiovascular ailments, especially amongst the geriatric population, and the growing need for effective medications and novel oncology-based therapies for diagnosis and treatment are primarily driving the market growth. Additionally, the rising demand for clinical-scale manufacturing of active pharmaceutical ingredients (APIs) by contract research, development, and manufacturing organizations (CRDMOs) and the shifting inclination toward biosimilars over format monoclonal antibodies are acting as other growth-inducing factors. Furthermore, the fueling health concerns have prompted biotechnology companies to engineer effective novel vaccines in collaboration with CRO, especially during the COVID-19 pandemic, which is contributing to the market growth. Moreover, the extensive utilization of in-vivo CRO to perform toxicology and pharmacokinetic studies during preclinical activities is impelling the market growth. Apart from this, the advent of bioequivalence, rapid growth in generics, ongoing patent expirations, and continuous research and development (R&D) activities to engineer personalized medicines are creating a positive outlook for the market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global in-vivo CRO market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, GLP type and indication.

Breakup by Type:

  • Rodent
  • Rats
  • Mice
  • Others
  • Non-Rodent

Breakup by GLP Type:

  • Non-GLP
  • In House
  • Outsourcing
  • GLP Toxicology
  • In House
  • Outsourcing

Breakup by Indication:

  • Autoimmune/Inflammation Conditions
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Osteoarthritis
  • Irritable Bowel Syndrome
  • Others
  • Pain Management
  • Chronic Pain
  • Acute Pain
  • Oncology
  • Blood Cancer
  • Solid Tumor
  • Others
  • CNS Conditions
  • Epilepsy
  • Parkinson's Disease
  • Huntington's Disease
  • Stroke
  • Traumatic Brain Injury
  • ALS
  • Muscle Regeneration
  • Others
  • Diabetes
  • Obesity
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories International Inc., Evotec SE, ICON plc, Iris Pharma (Abionyx Pharma), Labcorp Drug Development (Laboratory Corporation of America Holdings), North American Science Associates LLC, Parexel International Corporation, Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.), Pronexus Analytical AB, Syneos Health and WuXi AppTec.

Key Questions Answered in This Report:

  • How has the global in-vivo CRO market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global in-vivo CRO market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the GLP type?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global in-vivo CRO market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global In-vivo CRO Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Rodent
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Rats
      • 6.1.2.2 Mice
      • 6.1.2.3 Others
    • 6.1.3 Market Forecast
  • 6.2 Non-Rodent
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by GLP Type

  • 7.1 Non-GLP
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 In House
      • 7.1.2.2 Outsourcing
    • 7.1.3 Market Forecast
  • 7.2 GLP Toxicology
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 In House
      • 7.2.2.2 Outsourcing
    • 7.2.3 Market Forecast

8 Market Breakup by Indication

  • 8.1 Autoimmune/Inflammation Conditions
    • 8.1.1 Market Trends
    • 8.1.2 Key Segments
      • 8.1.2.1 Rheumatoid Arthritis
      • 8.1.2.2 Multiple Sclerosis
      • 8.1.2.3 Osteoarthritis
      • 8.1.2.4 Irritable Bowel Syndrome
      • 8.1.2.5 Others
    • 8.1.3 Market Forecast
  • 8.2 Pain Management
    • 8.2.1 Market Trends
    • 8.2.2 Key Segments
      • 8.2.2.1 Chronic Pain
      • 8.2.2.2 Acute Pain
    • 8.2.3 Market Forecast
  • 8.3 Oncology
    • 8.3.1 Market Trends
    • 8.3.2 Key Segments
      • 8.3.2.1 Blood Cancer
      • 8.3.2.2 Solid Tumor
      • 8.3.2.3 Others
    • 8.3.3 Market Forecast
  • 8.4 CNS Conditions
    • 8.4.1 Market Trends
    • 8.4.2 Key Segments
      • 8.4.2.1 Epilepsy
      • 8.4.2.2 Parkinson's Disease
      • 8.4.2.3 Huntington's Disease
      • 8.4.2.4 Stroke
      • 8.4.2.5 Traumatic Brain Injury
      • 8.4.2.6 ALS
      • 8.4.2.7 Muscle Regeneration
      • 8.4.2.8 Others
    • 8.4.3 Market Forecast
  • 8.5 Diabetes
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Obesity
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Evotec SE
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 ICON plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Iris Pharma (ABIONYX Pharma)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Labcorp Drug Development (Laboratory Corporation of America Holdings)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 SWOT Analysis
    • 14.3.6 North American Science Associates LLC
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Parexel International Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Pharmaceutical Product Development Inc. (Thermo Fisher Scientific Inc.)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Pronexus Analytical AB
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Syneos Health
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 WuXi AppTec
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials

List of Figures

  • Figure 1: Global: In-vivo CRO Market: Major Drivers and Challenges
  • Figure 2: Global: In-vivo CRO Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: In-vivo CRO Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: In-vivo CRO Market: Breakup by Type (in %), 2022
  • Figure 5: Global: In-vivo CRO Market: Breakup by GLP Type (in %), 2022
  • Figure 6: Global: In-vivo CRO Market: Breakup by Indication (in %), 2022
  • Figure 7: Global: In-vivo CRO Market: Breakup by Region (in %), 2022
  • Figure 8: Global: In-vivo CRO (Rodent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: In-vivo CRO (Rodent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: In-vivo CRO (Non-Rodent) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: In-vivo CRO (Non-Rodent) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: In-vivo CRO (Non-GLP) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: In-vivo CRO (Non-GLP) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: In-vivo CRO (GLP Toxicology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: In-vivo CRO (GLP Toxicology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: In-vivo CRO (Autoimmune/Inflammation Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: In-vivo CRO (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: In-vivo CRO (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: In-vivo CRO (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: In-vivo CRO (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: In-vivo CRO (CNS Conditions) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: In-vivo CRO (CNS Conditions) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: In-vivo CRO (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: In-vivo CRO (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: In-vivo CRO (Obesity) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: In-vivo CRO (Obesity) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: In-vivo CRO (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: In-vivo CRO (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: North America: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: North America: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: United States: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: United States: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Canada: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Canada: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Asia-Pacific: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Asia-Pacific: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: China: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: China: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Japan: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Japan: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: India: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: India: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: South Korea: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: South Korea: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Australia: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Australia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Indonesia: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Indonesia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Others: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Europe: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Europe: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Germany: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Germany: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: France: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: France: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: United Kingdom: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: United Kingdom: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Italy: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Italy: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Spain: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Spain: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Russia: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Russia: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Others: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Latin America: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Latin America: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Brazil: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Brazil: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Mexico: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Mexico: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Middle East and Africa: In-vivo CRO Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Middle East and Africa: In-vivo CRO Market: Breakup by Country (in %), 2022
  • Figure 78: Middle East and Africa: In-vivo CRO Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Global: In-vivo CRO Industry: SWOT Analysis
  • Figure 80: Global: In-vivo CRO Industry: Value Chain Analysis
  • Figure 81: Global: In-vivo CRO Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: In-vivo CRO Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: In-vivo CRO Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: In-vivo CRO Market Forecast: Breakup by GLP Type (in Million US$), 2023-2028
  • Table 4: Global: In-vivo CRO Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 5: Global: In-vivo CRO Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: In-vivo CRO Market: Competitive Structure
  • Table 7: Global: In-vivo CRO Market: Key Players